Why Many Patients Interested in Future Therapies May Already Have Higher Health Risks It is important to recognise that many individuals researching emerging weight-management treatments may already have underlying risk factors such as: obesity or metabolic syndrome type 2 diabetes high blood pressure elevated cholesterol sleep apnoea These conditions increase cardiovascular risk independently of any treatment
Most gastrointestinal events were classified as mild to moderate, and the majority were transient, resolving within the first several weeks of treatment or after dose stabilization
So yes, youre losing fat, but youre also losing things like muscle and bone mass, and those things are important, especially in older adults, and a lot of older adults have, you know, things like type 2 diabetes
They need to be repeatable
Exercise: Regular physical activity is essential for weight loss and overall health
Acute kidney injury : Though rare, any GLP-1 receptor agonist can potentially cause dehydration (particularly if severe vomiting or diarrhoea occurs), which may precipitate kidney problems